您的位置: 首页 > 农业专利 > 详情页

TUMOR SUPPRESSION USING HUMAN PLACENTAL PERFUSATE AND HUMAN PLACENTA-DERIVED INTERMEDIATE NATURAL KILLER CELLS
专利权人:
ANTHROGENESIS CORPORATION
发明人:
Robert J. Hariri,Mohammad A. Heidaran,Lin Kang,Neerav Dilip Padliya,Ajai Pal,Vanessa Voskinarian-Berse,Andrew Zeitlin,Xiaokui Zhang
申请号:
US14942337
公开号:
US20160287635A1
申请日:
2015.11.16
申请国别(地区):
US
年份:
2016
代理人:
摘要:
Provided herein are placental perfusate, placental perfusate cells, and placenta-derived intermediate natural killer cells, and combinations thereof. Also provided herein are compositions comprising the same, and methods of using placental perfusate, placental perfusate cells, and placenta-derived intermediate natural killer cells, and combinations thereof, to suppress the growth or proliferation of tumor cells, cancer cells, and the like, and to treat individuals having tumor cells.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充